Candel Therapeutics Stock Price on June 4, 2024
| CADL Stock | USD 4.95 0.33 7.14% |
If you're considering investing in Candel Stock, it is important to understand the factors that can impact its price. As of today, the current price of Candel Therapeutics stands at 4.95, as last reported on the 30th of November, with the highest price reaching 5.02 and the lowest price hitting 4.54 during the day. Candel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0607, which signifies that the company had a -0.0607% return per unit of risk over the last 3 months. Candel Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Candel Therapeutics' Standard Deviation of 4.75, mean deviation of 3.31, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
Total Stockholder Equity is expected to rise to about 13.4 M this year, although the value of Common Stock Total Equity will most likely fall to about 189.9 K. . At this time, Candel Therapeutics' Price Book Value Ratio is quite stable compared to the past year. Price To Book Ratio is expected to rise to 3.50 this year, although the value of Price Earnings Ratio will most likely fall to (1.18). Candel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Candel |
Sharpe Ratio = -0.0607
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CADL |
Estimated Market Risk
| 4.65 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Candel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Candel Therapeutics by adding Candel Therapeutics to a well-diversified portfolio.
Price Book 30.408 | Enterprise Value Ebitda (0.01) | Price Sales 436.4156 | Shares Float 21.7 M | Wall Street Target Price 11 |
Related Headline
Pharvaris Headline on 4th of June 2024
Pharvaris Highlights Properties of Deucrictibant in Data Pre... by benzinga.com
Deucrictibant substantially resolved symptoms of an HAE attack in 78.6 percent participants within 24 hoursHigh treatment satisfaction of deucrictibant driven by favorable effectiveness subdomain score compared to placebo ZUG,
Candel Therapeutics Valuation on June 4, 2024
It is possible to determine the worth of Candel Therapeutics on a given historical date. On June 4, 2024 Candel was worth 8.27 at the beginning of the trading date compared to the closed value of 8.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Candel Therapeutics stock. Still, in general, we apply an absolute valuation method to find Candel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Candel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Candel Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 8.99 | 9.05 | 8.14 | 8.37 | 683,310 | |
06/04/2024 | 8.27 | 8.55 | 7.94 | 8.04 | 371,188 |
| 7.85 | 8.55 | 7.85 | 8.03 | 588,003 |
| Backtest Candel Therapeutics | | | Candel Therapeutics History | | | Candel Therapeutics Valuation | Previous | Next |
Candel Therapeutics Trading Date Momentum on June 4, 2024
| On June 05 2024 Candel Therapeutics was traded for 8.03 at the closing time. The top price for the day was 8.55 and the lowest listed price was 7.85 . The trading volume for the day was 588 K. The trading history from June 5, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.12% . The overall trading delta against the current closing price is 6.09% . |
Candel Therapeutics Fundamentals Correlations and Trends
By evaluating Candel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Candel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Candel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Candel Therapeutics Stock history
Candel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Candel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Candel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Candel Therapeutics stock prices may prove useful in developing a viable investing in Candel Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.9 M | 23.2 M | |
| Net Loss | -16.9 M | -17.8 M |
Candel Therapeutics Quarterly Net Working Capital |
|
Candel Therapeutics Stock Technical Analysis
Candel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Candel Therapeutics Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Candel Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Candel Therapeutics November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Candel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Candel Therapeutics shares will generate the highest return on investment. By undertsting and applying Candel Therapeutics stock market strength indicators, traders can identify Candel Therapeutics entry and exit signals to maximize returns
Candel Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Candel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Candel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Candel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.27) | |||
| Total Risk Alpha | (0.96) | |||
| Treynor Ratio | (0.19) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Candel Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.73) | Revenue Per Share 0.001 | Return On Assets (0.52) | Return On Equity (4.81) |
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.